Prophylactic peritoneal dialysis catheter does not decrease time to achieve a negative fluid balance after the Norwood procedure: a randomized controlled trial
Lindsay M Ryerson, Andrew S Mackie, Joseph Atallah, Ari R Joffe, Ivan M Rebeyka, David B Ross, Ian Adatia, Lindsay M Ryerson, Andrew S Mackie, Joseph Atallah, Ari R Joffe, Ivan M Rebeyka, David B Ross, Ian Adatia
Abstract
Objective: Infants and children who undergo cardiopulmonary bypass and cardiac surgery are at risk of postoperative fluid overload. Peritoneal dialysis catheter (PDC) and peritoneal dialysis are reported to be effective means of postoperative fluid management. We sought to test the hypothesis that PDC insertion in the operating room at the time of Norwood palliation would decrease the time to achieve a negative fluid balance in a group of neonates with hypoplastic left heart syndrome.
Methods: A single center randomized controlled trial was performed. We randomized neonates with hypoplastic left heart syndrome to prophylactic PDC, with or without dialysis, or standard care (ie, no PDC).
Results: Twenty-two neonates were included; 10 were randomized to PDC and 12 were randomized to standard care. The mean time to first postoperative negative fluid balance was 2.70 ± 1.06 days for the prophylactic PDC group and 2.67 ± 0.65 days for the standard care group (P = .93). There was no difference between the 2 groups in time to lactate ≤ 2 mmol/L, maximum vasoactive-inotrope score on postoperative days 2 to 5, time to sternal closure, time to first extubation, modified clinical outcome score, or hospital length of stay. Twenty-one patients (95%) survived to hospital discharge. Four patients randomized to prophylactic PDC had 1 or more serious adverse events compared with no patients in the standard care group (P = .03).
Conclusions: Prophylactic PDC, with or without dialysis, did not decrease the time to achieve a negative fluid balance after the Norwood procedure, did not alter physiological variables postoperatively, and was associated with more severe adverse events.
Trial registration: ClinicalTrials.gov NCT01215240.
Copyright © 2015 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.
Source: PubMed
다가오는 임상 시험
-
Sohag University아직 모집하지 않음
-
Stanford University아직 모집하지 않음
-
Tianjin Eye Hospital모병
-
Neuralink Corp모병
-
National Institute of Diabetes and Digestive and...아직 모집하지 않음
-
National Heart, Lung, and Blood Institute (NHLBI)아직 모집하지 않음
-
National Cancer Institute (NCI)아직 모집하지 않음비소세포폐암 | NSCLC | 폐암 | 전립선암 | mCRPC | 전이성 거세저항성 전립선암 | 흉선 상피 종양 | TETs | Thymic Carcinomas | Thymomas미국
-
National Institute of Dental and Craniofacial Research...아직 모집하지 않음비만 | 폐쇄성 수면 무호흡증(OSA) | 상악 저형성증 | 하악 저산소증 | Pediatric Obstructive Sleep Apnea (OSA) | Adeno-Tonsillar Hypertrophy | Intraoral Appliance미국
-
National Institute of Allergy and Infectious Diseases...아직 모집하지 않음
-
National Heart, Lung, and Blood Institute (NHLBI)아직 모집하지 않음비대성 심근병증 | Left Ventricular Outflow Obstruction | Systolic Anterior Motion미국
-
National Institute of Neurological Disorders and...아직 모집하지 않음